share_log

Needham Maintains Buy on NuVasive, Lowers Price Target to $53

Needham Maintains Buy on NuVasive, Lowers Price Target to $53

Needham 维持对NuvaSive的买入,将目标价下调至53美元
Benzinga Real-time News ·  2022/09/30 05:28

Needham analyst David Saxon maintains NuVasive (NASDAQ:NUVA) with a Buy and lowers the price target from $67 to $53.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发